PepGen Inc.

Organization

Cambridge, MA, US

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Antitumor and antiviral combination therapies using low-toxicity, l...
- Patent number 7,695,710
- Issue date Apr 13, 2010
- Pepgen Corporation
- Lorelie H. Villarete
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Low-toxicity, long-circulating human interferon-alpha PEGylated mut...
- Patent number 7,662,370
- Issue date Feb 16, 2010
- Pepgen Corporation
- Lorelie H. Villarete
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of treating IL-10 deficiency
- Patent number 7,431,920
- Issue date Oct 7, 2008
- Pepgen Corporation
- Chih-Ping Liu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Hybrid interferon/interferon tau proteins, compositions and methods...
- Patent number 7,232,563
- Issue date Jun 19, 2007
- Pepgen Corporation
- Lorelie H. Villarete
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of treatment using interferon-tau
- Patent number 7,105,154
- Issue date Sep 12, 2006
- Pepgen Corporation
- Yoshihiro Sokawa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of treatment using interferon-tau
- Patent number 7,083,782
- Issue date Aug 1, 2006
- Pepgen Corporation
- Chih-Ping Liu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Composition for treatment of and method of monitoring hepatitis C v...
- Patent number 6,982,081
- Issue date Jan 3, 2006
- Pepgen Corporation
- Yoshihiro Sokawa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Low-toxicity human interferon-alpha analogs
- Patent number 6,204,022
- Issue date Mar 20, 2001
- Pepgen Corporation and University of Florida
- Howard M. Johnson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Please log in for detailed analytics

Patents Applicationslast 30 patents

Information Patent Application
METHODS OF TREATING DUCHENNE MUSCULAR DYSTROPHY USING PEPTIDE-OLIGO...
- Publication number 20240200062
- Publication date Jun 20, 2024
- PepGen Inc.
- Caroline GODFREY
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS OF TREATING MYOTONIC DYSTROPHY TYPE 1 USING PEPTIDE-OLIGONU...
- Publication number 20240189434
- Publication date Jun 13, 2024
- PepGen Inc.
- Caroline GODFREY
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Combination treatment method with interferon-tau
- Publication number 20090035273
- Publication date Feb 5, 2009
- Pepgen Corporation
- Chih-Ping Liu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compositions and methods for modulation of immune responses
- Publication number 20070081991
- Publication date Apr 12, 2007
- Pepgen Corporation
- Karl Petter Soderstrom
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Treatment using an interferon
- Publication number 20060257363
- Publication date Nov 16, 2006
- Pepgen Corporation
- Chih-Ping Liu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Method of treatment using interferon-tau
- Publication number 20060134750
- Publication date Jun 22, 2006
- Pepgen Corporation
- Chih-Ping Liu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Method of treatment using interferon-tau
- Publication number 20060078942
- Publication date Apr 13, 2006
- Pepgen Corporation
- Chih-Ping Liu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Composition for treatment of and method of monitoring hepatitis C v...
- Publication number 20050244373
- Publication date Nov 3, 2005
- Pepgen Corporation
- Yoshihiro Sokawa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Please log in for detailed analytics

Trademarklast 30 trademarks

Information Trademark
97622958 - EMPOWERING OLIGONUCLEOTIDE THERAPEUTICS
- Serial number 97622958
- Registration number 7025936
- Filing date Oct 7, 2022
- PepGen Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
97269471 - P PEPGEN
- Serial number 97269471
- Registration number 7005932
- Filing date Feb 16, 2022
- PepGen Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
78797060 - PEPGEN
- Serial number 78797060
- Filing date Jan 23, 2006
- PEPGEN CORPORATION
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
78797045 - NEOFERON
- Serial number 78797045
- Filing date Jan 23, 2006
- PEPGEN CORPORATION
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
78797107 - TAOFERON
- Serial number 78797107
- Filing date Jan 23, 2006
- PEPGEN CORPORATION
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
78236450 - NEOFERON
- Serial number 78236450
- Filing date Apr 10, 2003
- PEPGEN CORPORATION
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
78142033 - PG
- Serial number 78142033
- Filing date Jul 8, 2002
- PEPGEN CORPORATION
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
78138199 - PEPGEN
- Serial number 78138199
- Filing date Jun 24, 2002
- PEPGEN CORPORATION
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
78136573 - TAUFERON
- Serial number 78136573
- Filing date Jun 18, 2002
- PEPGEN CORPORATION
- 5 - Pharmaceutical and veterinary preparations

NIH Research Projectlast 12 months

processing...

Count: 8

Research Projects

Information Research Project
Oral IFN-tau treatment in RRMS patients
- Application id 6859382
- Award notice date Feb 24, 2005
Information Research Project
IFN-tau treatment in mice infected with cowpox virus
- Application id 6735965
- Award notice date Sep 7, 2004
Information Research Project
Non-toxic Human Interferon-Alpha Analog
- Application id 6779182
- Award notice date Jun 23, 2004
Information Research Project
Oral IFN-tau treatment in RRMS patients
- Application id 6735856
- Award notice date Feb 23, 2004
Information Research Project
Oral Interferon Treatment in collagen induced arthritis
- Application id 6694022
- Award notice date Aug 30, 2003
Information Research Project
Non-toxic Human Interferon-Alpha Analog
- Application id 6692059
- Award notice date Jul 18, 2003
Information Research Project
Non-toxic Human Interferon-Alpha Analog
- Application id 6444197
- Award notice date Feb 15, 2002
Information Research Project
SYNTHETIC GENE FOR PLACENTAL UTEROFERRIN
- Application id 2147626
- Award notice date May 31, 1995

PepGen Inc.

Organization

Patents Grantslast 30 patents

Antitumor and antiviral combination therapies using low-toxicity, l...

Low-toxicity, long-circulating human interferon-alpha PEGylated mut...

Method of treating IL-10 deficiency

Hybrid interferon/interferon tau proteins, compositions and methods...

Method of treatment using interferon-tau

Method of treatment using interferon-tau

Composition for treatment of and method of monitoring hepatitis C v...

Low-toxicity human interferon-alpha analogs

Patents Applicationslast 30 patents

METHODS OF TREATING DUCHENNE MUSCULAR DYSTROPHY USING PEPTIDE-OLIGO...

METHODS OF TREATING MYOTONIC DYSTROPHY TYPE 1 USING PEPTIDE-OLIGONU...

Combination treatment method with interferon-tau

Compositions and methods for modulation of immune responses

Treatment using an interferon

Method of treatment using interferon-tau

Method of treatment using interferon-tau

Composition for treatment of and method of monitoring hepatitis C v...

Trademarklast 30 trademarks

97622958 - EMPOWERING OLIGONUCLEOTIDE THERAPEUTICS

97269471 - P PEPGEN

78797060 - PEPGEN

78797045 - NEOFERON

78797107 - TAOFERON

78236450 - NEOFERON

78142033 - PG

78138199 - PEPGEN

78136573 - TAUFERON

NIH Research Projectlast 12 months

Research Projects

Oral IFN-tau treatment in RRMS patients

IFN-tau treatment in mice infected with cowpox virus

Non-toxic Human Interferon-Alpha Analog

Oral IFN-tau treatment in RRMS patients

Oral Interferon Treatment in collagen induced arthritis

Non-toxic Human Interferon-Alpha Analog

Non-toxic Human Interferon-Alpha Analog

SYNTHETIC GENE FOR PLACENTAL UTEROFERRIN